Xometry, Inc. (NASDAQ:XMTR – Get Free Report) President Sanjeev Singh Sahni sold 9,978 shares of the firm’s stock in a transaction on Thursday, February 26th. The stock was sold at an average price of $43.45, for a total transaction of $433,544.10. Following the completion of the sale, the president owned 113,022 shares of the company’s stock, valued at $4,910,805.90. This trade represents a 8.11% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Sanjeev Singh Sahni also recently made the following trade(s):
- On Thursday, January 8th, Sanjeev Singh Sahni sold 26,190 shares of Xometry stock. The stock was sold at an average price of $65.47, for a total transaction of $1,714,659.30.
- On Monday, January 5th, Sanjeev Singh Sahni sold 4,446 shares of Xometry stock. The stock was sold at an average price of $66.57, for a total transaction of $295,970.22.
Xometry Price Performance
Shares of NASDAQ:XMTR opened at $41.01 on Friday. Xometry, Inc. has a 52 week low of $18.59 and a 52 week high of $73.87. The company has a 50-day moving average price of $60.65 and a 200 day moving average price of $56.08. The company has a market cap of $2.10 billion, a P/E ratio of -33.61 and a beta of 0.86. The company has a quick ratio of 3.58, a current ratio of 3.76 and a debt-to-equity ratio of 1.18.
Trending Headlines about Xometry
Here are the key news stories impacting Xometry this week:
- Positive Sentiment: Company delivered a solid quarter — revenue grew ~29.5% year‑over‑year and Q4 EPS beat consensus, supporting the long‑term growth story. Read More.
- Positive Sentiment: Management will attend investor conferences (including a March 3 fireside chat), giving investors more access to management and clarity on the upcoming CEO transition. Read More.
- Positive Sentiment: Some firms remain constructive — Citigroup and Wedbush kept buy/outperform stances even while trimming targets, which preserves upside conviction among bullish investors. Read More.
- Neutral Sentiment: A number of analysts adjusted targets with mixed tones — UBS and Royal Bank of Canada moved to neutral/sector‑perform levels, trimming upside but not issuing outright sell calls. This reduces short‑term consensus upside but isn’t uniformly bearish. Read More.
- Neutral Sentiment: Institutional ownership is very high (~97%), so large insider transactions and analyst flows can disproportionately influence intraday liquidity and volatility. Read More.
- Negative Sentiment: Significant, contemporaneous insider selling — CEO, CFO, President, CTO and other insiders reported multi‑thousand‑share sales on Feb. 26. Heavy insider sales on the same day typically spook investors and add downward pressure. Read More.
- Negative Sentiment: Analyst downgrades and target cuts triggered selling flow — several outlets reported the stock drifting lower after the analyst actions, which appears to be a primary catalyst for today’s weakness. Read More.
- Negative Sentiment: Conflicting narratives around the earnings release (some headlines emphasizing the beat, others highlighting margin/negative net income issues) increase short‑term uncertainty and volatility. Read More.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on XMTR. Cantor Fitzgerald increased their price target on shares of Xometry from $41.00 to $60.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. The Goldman Sachs Group upped their target price on shares of Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. UBS Group lifted their price target on shares of Xometry from $54.00 to $55.00 and gave the company a “neutral” rating in a research report on Wednesday. JPMorgan Chase & Co. boosted their price target on Xometry from $55.00 to $70.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Finally, Zacks Research downgraded Xometry from a “hold” rating to a “strong sell” rating in a research note on Friday, January 30th. Five investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Xometry has a consensus rating of “Hold” and a consensus target price of $62.00.
Check Out Our Latest Stock Report on XMTR
Institutional Trading of Xometry
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Kemnay Advisory Services Inc. acquired a new stake in shares of Xometry during the fourth quarter valued at $28,000. Quantbot Technologies LP acquired a new stake in shares of Xometry during the 3rd quarter worth about $30,000. Advisors Asset Management Inc. grew its holdings in shares of Xometry by 68.3% during the second quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company’s stock worth $34,000 after buying an additional 412 shares in the last quarter. Westend Capital Management LLC purchased a new stake in shares of Xometry during the third quarter worth about $41,000. Finally, GAMMA Investing LLC raised its position in shares of Xometry by 26.5% in the fourth quarter. GAMMA Investing LLC now owns 773 shares of the company’s stock valued at $46,000 after buying an additional 162 shares during the last quarter. 97.31% of the stock is currently owned by hedge funds and other institutional investors.
Xometry Company Profile
Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.
Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.
Featured Stories
- Five stocks we like better than Xometry
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.
